Actinium Pharmaceuticals IncNYSE American:ATNM
- LAST PRICE1.4500
- TODAY'S CHANGE (%)-0.0200 (-1.3605%)
- Bid / Lots1.4100/ 1
- Ask / Lots1.5700/ 2
- Open / Previous Close1.4700 / 1.4700
- Day Range
- 52 Week Range
- Volume222,701
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATNM |
|---|---|---|
| 09:32 ET | 4843 | 1.46 |
| 09:35 ET | 300 | 1.47 |
| 09:37 ET | 435 | 1.44 |
| 09:44 ET | 100 | 1.43 |
| 09:48 ET | 100 | 1.43 |
| 09:50 ET | 1300 | 1.45 |
| 09:51 ET | 5179 | 1.43 |
| 09:53 ET | 333 | 1.435 |
| 09:55 ET | 3352 | 1.46 |
| 09:57 ET | 1139 | 1.465 |
| 10:02 ET | 100 | 1.465 |
| 10:06 ET | 900 | 1.46 |
| 10:11 ET | 600 | 1.46 |
| 10:13 ET | 100 | 1.465 |
| 10:18 ET | 100 | 1.465 |
| 10:20 ET | 1114 | 1.4654 |
| 10:24 ET | 1166 | 1.465 |
| 10:26 ET | 500 | 1.47 |
| 10:27 ET | 200 | 1.47 |
| 10:29 ET | 200 | 1.465 |
| 10:33 ET | 288 | 1.46 |
| 10:38 ET | 600 | 1.46 |
| 10:45 ET | 400 | 1.465 |
| 10:49 ET | 4009 | 1.45 |
| 10:58 ET | 1400 | 1.455 |
| 11:00 ET | 416 | 1.455 |
| 11:02 ET | 100 | 1.45 |
| 11:03 ET | 1500 | 1.455 |
| 11:07 ET | 450 | 1.4536 |
| 11:09 ET | 1100 | 1.45 |
| 11:12 ET | 1026 | 1.45 |
| 11:16 ET | 306 | 1.45 |
| 11:20 ET | 1444 | 1.455 |
| 11:34 ET | 165 | 1.465 |
| 11:38 ET | 100 | 1.46 |
| 11:39 ET | 8300 | 1.48 |
| 11:41 ET | 1600 | 1.48 |
| 11:43 ET | 1906 | 1.46 |
| 11:45 ET | 4700 | 1.46 |
| 11:48 ET | 10875 | 1.465 |
| 11:50 ET | 6605 | 1.46 |
| 11:52 ET | 13027 | 1.435 |
| 11:56 ET | 1000 | 1.44 |
| 11:57 ET | 100 | 1.44 |
| 11:59 ET | 1000 | 1.445 |
| 12:01 ET | 400 | 1.45 |
| 12:06 ET | 100 | 1.45 |
| 12:08 ET | 200 | 1.45 |
| 12:10 ET | 200 | 1.45 |
| 12:12 ET | 300 | 1.45 |
| 12:14 ET | 100 | 1.45 |
| 12:15 ET | 650 | 1.445 |
| 12:17 ET | 400 | 1.45 |
| 12:19 ET | 200 | 1.44 |
| 12:21 ET | 100 | 1.45 |
| 12:24 ET | 600 | 1.45 |
| 12:26 ET | 2800 | 1.45 |
| 12:28 ET | 100 | 1.45 |
| 12:30 ET | 200 | 1.45 |
| 12:32 ET | 100 | 1.45 |
| 12:33 ET | 300 | 1.45 |
| 12:35 ET | 2100 | 1.45 |
| 12:37 ET | 1000 | 1.445 |
| 12:39 ET | 300 | 1.45 |
| 12:42 ET | 1200 | 1.44 |
| 12:44 ET | 300 | 1.445 |
| 12:46 ET | 269 | 1.445 |
| 12:48 ET | 2950 | 1.47 |
| 12:50 ET | 265 | 1.461 |
| 12:51 ET | 1500 | 1.47 |
| 12:53 ET | 720 | 1.465 |
| 12:55 ET | 200 | 1.47 |
| 01:00 ET | 466 | 1.4613 |
| 01:02 ET | 600 | 1.46 |
| 01:06 ET | 300 | 1.45 |
| 01:08 ET | 568 | 1.45 |
| 01:09 ET | 200 | 1.45 |
| 01:13 ET | 100 | 1.45 |
| 01:24 ET | 100 | 1.455 |
| 01:26 ET | 388 | 1.45 |
| 01:29 ET | 100 | 1.45 |
| 01:31 ET | 124 | 1.45 |
| 01:33 ET | 100 | 1.45 |
| 01:38 ET | 320 | 1.45 |
| 01:40 ET | 100 | 1.45 |
| 01:42 ET | 336 | 1.45 |
| 01:44 ET | 10330 | 1.442 |
| 01:45 ET | 100 | 1.44 |
| 01:47 ET | 1300 | 1.43 |
| 01:49 ET | 100 | 1.43 |
| 01:51 ET | 343 | 1.43 |
| 01:54 ET | 306 | 1.4315 |
| 01:56 ET | 1100 | 1.43 |
| 01:58 ET | 288 | 1.43 |
| 02:00 ET | 100 | 1.43 |
| 02:03 ET | 3200 | 1.44 |
| 02:05 ET | 400 | 1.435 |
| 02:07 ET | 200 | 1.44 |
| 02:09 ET | 398 | 1.435 |
| 02:12 ET | 3017 | 1.445 |
| 02:16 ET | 10200 | 1.445 |
| 02:18 ET | 100 | 1.445 |
| 02:20 ET | 120 | 1.4456 |
| 02:21 ET | 100 | 1.4443 |
| 02:23 ET | 500 | 1.4408 |
| 02:30 ET | 300 | 1.44 |
| 02:32 ET | 200 | 1.44 |
| 02:39 ET | 100 | 1.44 |
| 02:41 ET | 300 | 1.44 |
| 02:43 ET | 300 | 1.445 |
| 02:45 ET | 500 | 1.4419 |
| 02:48 ET | 100 | 1.44 |
| 02:50 ET | 337 | 1.4495 |
| 02:52 ET | 483 | 1.44 |
| 02:56 ET | 424 | 1.44 |
| 02:59 ET | 300 | 1.44 |
| 03:01 ET | 200 | 1.44 |
| 03:03 ET | 1379 | 1.44 |
| 03:06 ET | 100 | 1.4389 |
| 03:08 ET | 824 | 1.43 |
| 03:14 ET | 100 | 1.435 |
| 03:19 ET | 500 | 1.435 |
| 03:21 ET | 1300 | 1.4394 |
| 03:26 ET | 900 | 1.43 |
| 03:28 ET | 3241 | 1.43 |
| 03:30 ET | 1916 | 1.415 |
| 03:32 ET | 200 | 1.415 |
| 03:33 ET | 3500 | 1.4299 |
| 03:37 ET | 100 | 1.435 |
| 03:39 ET | 1300 | 1.43 |
| 03:42 ET | 3145 | 1.425 |
| 03:44 ET | 4224 | 1.41 |
| 03:46 ET | 1838 | 1.42 |
| 03:48 ET | 3535 | 1.435 |
| 03:50 ET | 100 | 1.435 |
| 03:51 ET | 1000 | 1.435 |
| 03:53 ET | 1000 | 1.435 |
| 03:55 ET | 100 | 1.435 |
| 03:57 ET | 200 | 1.435 |
| 04:00 ET | 15195 | 1.45 |
Nov 19, 2024
DJ Actinium Pharmaceuticals Price Target Maintained With a $5.00/Share by Stephens & Co., from 1:03PM ET on Tuesday Nov 19, 2024 by Dow Jones
1:03PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 18, 2024
*DJ Actinium Pharma: Cash and Cash Equivalents of About $78.6 M as of Sept 30 Expected to Fund Ops Into 2027 >ATNM, from 8:04AM ET on Monday Nov 18, 2024 by Dow Jones
8:04AM ET on Monday Nov 18, 2024 by Dow JonesActinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024, from 8:00AM ET on Monday Nov 18, 2024 by Dow Jones
8:00AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 15, 2024
DJ Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co., from 2:25PM ET on Friday Nov 15, 2024 by Dow Jones
2:25PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 4, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Actinium Pharmaceuticals Inc | 45.2M | -1.0x | --- |
Gain Therapeutics Inc | 44.7M | -1.5x | --- |
Serina Therapeutics Inc | 44.9M | -1.1x | --- |
OKYO Pharma Ltd | 35.5M | -1.5x | --- |
CalciMedica Inc | 46.5M | -2.2x | --- |
IO Biotech Inc | 46.6M | -0.5x | --- |
Company Information
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.
Contact Information
- Headquarters
- 100 Park Ave., 23Rd FloorNEW YORK, NY, United States 10017
- Phone
- 646-677-3870
- Fax
- 845-818-3588
Executives
- Chairman of the Board, Chief Executive Officer
- Sandesh Seth
- Chief Financial Officer
- Steve O'Loughlin
- Chief Business Officer
- Lynn Bodarky
- Director
- June Almenoff
- Independent Director
- Jeffrey Chell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $45.2M |
|---|---|
Revenue (TTM) | $81.0K |
Shares Outstanding | 31.2M |
Actinium Pharmaceuticals Inc does not pay a dividend. | |
Beta | 0.09 |
EPS | $-1.40 |
Book Value | $1.32 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 558.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -55,504.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
